Home/Filings/4/0001235802-24-000052
4//SEC Filing

Kellen Scott 4

Accession 0001235802-24-000052

CIK 0001401040other

Filed

Jun 2, 8:00 PM ET

Accepted

Jun 3, 4:59 PM ET

Size

6.2 KB

Accession

0001235802-24-000052

Insider Transaction Report

Form 4
Period: 2024-06-01
Kellen Scott
CFO & Secretary
Transactions
  • Award

    Stock Option (right to buy)

    2024-06-01+130,000130,000 total
    Exercise: $2.90Exp: 2034-05-31Common Shares (130,000 underlying)
Holdings
  • Voting Common Shares, no par value per share

    32,290
Footnotes (1)
  • [F1]Vests with respect to 25% of the underlying common shares on June 1, 2025 and with respect to the remaining 75% of the underlying common shares vesting quarterly over the following three years commencing on September 1, 2025.

Issuer

DiaMedica Therapeutics Inc.

CIK 0001401040

Entity typeother

Related Parties

1
  • filerCIK 0001490476

Filing Metadata

Form type
4
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 4:59 PM ET
Size
6.2 KB